País: Jordânia
Língua: inglês
Origem: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Levetiracetam 500 mg
مستودع أدوية سليمان طنوس وأولاده - Suleiman Tannous & Sons Co. Ltd
N03AX14
Levetiracetam 500 mg
500 mg
100
يوسي بي فارما (بلجيكا)
42.97 :سعر الجمهور + الضريبة
HARMONY _Packaging artwork and technical drawings _ _Approval Information_ Page 1 of 3 PROJECT: CO-0042959 DOCUMENT: PPC-0027412.pdf DOCUMENT DESCRIPTION: VERSION: 3 VERSION ID: 00002_0001104088 DOWNLOADED: Sep 8, 2021 at 10:04 AM GMT+04:00 BY: Lakkis, Fadilla (FML41544) APPROVAL STATE: DRAFT PATIENT LEAFLET 250 MG; 500 MG; 1000 MG FILM-COATED TABLETS Read all of this leaflet carefully before you start taking this medicine. − Keep this leaflet. You may need to read it again. − If you have any questions, ask your doctor or pharmacist. − This medicine has been prescribed for you personally or your child. Don’t pass it on to other people - it may harm them even if their symptoms seem to be the same as yours. − If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET 1. WHAT KEPPRA IS AND WHAT IT IS USED FOR 2. BEFORE YOU TAKE KEPPRA 3. HOW TO TAKE KEPPRA 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE KEPPRA 6. FURTHER INFORMATION 1. WHAT KEPPRA IS AND WHAT IT IS USED FOR Keppra contains the active ingredient levetiracetam. It belongs to antiepileptic medicines, which are used to treat fits ( seizures ) in epilepsy. On its own, Keppra is used to treat: • partial onset seizure with or without secondary generalisation (the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain) - in adults and adolescents from 16 years of age with newly diagnosed epilepsy As an add-on to other antiepileptic medicines, Keppra is used to treat: • partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age with epilepsy • myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy • primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in adults an Leia o documento completo